Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Monoclonal Antibodies against Cancer: Present and Future
Marisa Delgado, José A. García‐Sanz
Cells (2023) Vol. 12, Iss. 24, pp. 2837-2837
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Recent Therapeutic Advances in Gynecologic Oncology: A Review
Elise Wilson, Ramez N. Eskander, Pratibha Binder
Cancers (2024) Vol. 16, Iss. 4, pp. 770-770
Open Access | Times Cited: 8
The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention
Jannifer Jasmin Thavarajah, Bo Langhoff Hønge, Christian Wejse
(2024)
Open Access | Times Cited: 5
Ion exchange chromatography of biotherapeutics: Fundamental principles and advanced approaches
Mateusz Imiołek, Szabolcs Fekete, Serge Rudaz, et al.
Journal of Chromatography A (2025) Vol. 1742, pp. 465672-465672
Open Access
A bispecific antibody overcomes limitations of prior strategies to achieve effective and tumor-selective Death Receptor 5 (DR5) clustering
Victor S. Goldmacher, Iosif M. Gershteyn, Ravi Chari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The role of monoclonal antibodies in the treatment of pancreatic and colon cancers
Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 389-412
Closed Access
Gene Editing in ErbB/HER Family-Mediated Cancer Immunology
Ling Yin
IntechOpen eBooks (2025)
Closed Access
Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
Akram N. Salah, Amr H. Hashem, Mohamed Bakr Zaki, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
The Use of Biologics for Targeting GPCRs in Metastatic Cancers
Cian McBrien, David O’Connell
BioTech (2025) Vol. 14, Iss. 1, pp. 7-7
Open Access
A Genetically Encoded Endogenous Antibody Recruitment Strategy for Innate Immune‐Mediated Killing of Cancer Cells
Justine Aelvoet, Zifu Zhong, C. Gómez, et al.
Advanced Materials (2025)
Closed Access
Cancer stem cell analysis and targeting
Mishal Safdar, Z. M. Amin, Muneeb Ullah, et al.
Methods in cell biology (2025)
Closed Access
Renale Nebenwirkungen neuer onkologischer Therapien
Susanne Delécluse, Ralph Wendt
Uro-News (2025) Vol. 29, Iss. 3, pp. 38-45
Closed Access
Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies
Jianlin Zhou, Xinjie Lu, Rui-Rui He, et al.
Science China Life Sciences (2025)
Closed Access
The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention
Jannifer Jasmin Thavarajah, Bo Langhoff Hønge, Christian Wejse
Viruses (2024) Vol. 16, Iss. 6, pp. 911-911
Open Access | Times Cited: 2
Staging und Systemtherapie bei okulären und periokulären Metastasen
Daniela Dörfel, Neele Babst, Ludwig Maximillian Heindl, et al.
Deleted Journal (2024) Vol. 121, Iss. 5, pp. 374-381
Closed Access | Times Cited: 1
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Nanobodies: from high-throughput identification to therapeutic development
Peter C. Fridy, Michael P. Rout, Natalia E. Ketaren
Molecular & Cellular Proteomics (2024), pp. 100865-100865
Open Access | Times Cited: 1
Beyond ADCs: Harnessing Bispecific Antibodies to Directly Induce Apoptosis for Targeted Tumor Eradication
Victor S. Goldmacher, Iosif M. Gershteyn, Yelena Kovtun
Antibody Therapeutics (2024) Vol. 7, Iss. 4, pp. 351-360
Open Access | Times Cited: 1
Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review
Magdalena Kędzierska, Magdalena Bańkosz
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7131-7131
Open Access | Times Cited: 1
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies
Dušan Babić, Ivana Jovčevska, Alja Zottel
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Spectrum of renal side effects of new oncological therapies
Susanne Delécluse, Ralph Wendt
Deleted Journal (2024)
Closed Access
Missed opportunities to increase efficiency of monoclonal antibody development using hybridoma technology and mice as the source animal
Esha Chakravarty, M. Tevfik Dorak
Frontiers in Immunology (2024) Vol. 15
Open Access
Targeted Drug Delivery in Periorbital Non-Melanocytic Skin Malignancies
Benedetta Tirone, Anna Scarabosio, Pier Luigi Surico, et al.
Bioengineering (2024) Vol. 11, Iss. 10, pp. 1029-1029
Open Access
Evaluation of orphan maintained biological medicinal products in the European Union between 2018 to 2023: a regulatory perspective
Paolo Caferra, T. Fraisse, Maria Letizia Trincavelli, et al.
Expert Opinion on Biological Therapy (2024)
Closed Access
A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy
Manqing Peng, Xiaofang Lu, Junshuang Guo, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Therapeutic mRNAs for cancer immunotherapy: From structure to delivery
Monika Vishwakarma, Wasim Akram, Tanweer Haider
Advances in immunology (2024)
Closed Access
Page 1 - Next Page

Scroll to top